06:07 EDT Alaunos Therapeutics (TCRT) files $50M mixed securities shelf
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCRT:
- Alaunos Therapeutics Regains Nasdaq Compliance
- Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
- Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
- Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
- Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors